The Limulus amebocyte lysate (LAL) assay is a sensitive method for detecting endotoxin. Using gramnegative (GN) bacteremia as the basis for comparison, concordance with endotoxemia in 45 studies could be expressed as an odds ratio. Calculation of summary odds ratios by the Mantel-Haenszel-Peto method indicated that the concordance of the results was no higher by the chromogenic LAL assay than by the gelation version, and the sensitivity was improved by only 11% (62 versus 51%). Endotoxemia was detected in 77 (68%) of 114 patients with bacteremia caused by an organism that was not a member of the family Enterobacteriaceae, whereas endotoxemia was detected in only 120 (45%) of 269 patients with bacteremia caused by a member of the family Enterobacteriaceae or an anaerobe (P < 0.001). This difference was also apparent for patients with GN bacteremia for whom a fatal outcome had been recorded. The prevalence of GN bacteremia in the tested population and the type of etiological agent are critical and previously unrecognized variables which affect the interpretation of the LAL test in patients with suspected sepsis.
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Endotoxin is a cell wall component found exclusively in gram-negative (GN) bacteria. Considerable experience has accumulated with the use of the Limulus amebocyte lysate (LAL) for the detection of endotoxin in various body fluids (20) . For example, when applied to samples of cerebrospinal fluid for the detection of GN meningitis, the LAL assay has a sensitivity and a specificity each greater than 95%, in comparison with the sensitivity of Gram stain examination, which is only 81% (58) .
By contrast, its value as a diagnostic test when applied to plasma samples remains unclear, despite more than 45 studies. With the detection of GN bacteremia as the basis for comparison, its sensitivity and specificity are less than 85% (20) . Several estimates made on the basis of experimental (65) and clinical (8, 11, 64) data suggest that the minimum amount of endotoxin required to induce a positive LAL test result would be equivalent to that contained in at least 100 GN bacteria per ml, a level that is seldom reached in patients with clinical bacteremia. In addition, plasma contains incompletely defined factors that interfere with the detection of endotoxin (32, 41, 57) or that confound the reading of the assay (32) .
To overcome these obstacles, the assay has been modified. In 1983, a chromogenic substrate (CLAL) was introduced as a more sensitive indicator of LAL activation by endotoxin. The CLAL assay is sensitive to endotoxin in plasma samples spiked in vitro at concentrations 10 times lower than those used in the previous gelation end point (GLAL) assay (28) . However, there has been no direct comparative study of the two assays on samples from patients with GN bacteremia.
Additional considerations have come to light more recently. It has long been assumed, and implied in the term itself, that endotoxin is released only on death and lysis of the bacterial cell. Recently, it has been recognized that endotoxin is shed from the surface of certain GN bacteria in the absence of lysis and that this property is not equally expressed by different GN bacteria (62) . For example, it is observed more often with invasive than with mucosal isolates of Neisseria meningitidis (2, 49) .
A third consideration relates to the patient population. The proportion of patients with GN bacteremia is a key indicator of the patient mix in studies which may or may not have been designed for the purpose of examining the diagnostic application of the assay. In large published series of studies of patients satisfying generally accepted criteria of suspected GN sepsis, this proportion is usually in the range of 13 to 40%. For example, in five such studies, the proportions were 13% (22), 25% (53) , 30% (6), 37% (74) , and 40% (71).
The purpose of this review is to examine the diagnostic experience with endotoxemia detection by using GN bacteremia as the basis for comparison. The value of the more sensitive CLAL assay, the etiological agents of the bacteremias, and the prevalence of GN bacteremia in the patient population were three factors identified for special attention. The statistical techniques of meta-analysis are used. These techniques evolved from their application to the evaluation of retrospective studies of disease (24a, 45a) .
MATERMILS AND METHODS
Study selection. A review of the literature was performed.
The review included a search of the Medline database back to 1972, with the search headings being "septicemia" (prior to 1992), "bacteremia" (from 1992 on), "endotoxins," and "human." The search was not limited to reports published in the English language (13, 34) and included conference proceedings (14, 19, 48, 69) . This was supplemented with a manual search of the references from each report retrieved, review articles, and textbooks. The following criteria were used in selecting studies for inclusion: (i) study design, which included a direct comparison of blood culture and LAL (or Tachypleus amebocyte lysate [67] ) assay methods applied to blood from patients suspected of having GN sepsis; (ii) size, with at least four patients studied; and (iii) data presentation, such that each patient could be classified into one of four possible categories: category 1, blood cultures, GN bacteria, and endotoxin positive; category 2, blood cultures, GN bacteria, and endotoxin negative; category 3, blood cultures, no GN bacteria, and endotoxin positive; and category 4, blood cultures, no GN bacteria, and endotoxin negative.
Unpublished data were sought directly from the authors of studies who had published results in a form which did not meet the above criteria to seek a clarification that would have enabled inclusion. The exclusion criteria were duplicate publication and application of the assay to patients with conditions other than suspected sepsis. Twenty-eight studies were excluded (the list is available on request). For one study (33) , only the data from the examination of systemic blood were included and the data for portal blood examination were excluded.
Data analysis. For each study, the concordance of the results of the two tests was expressed as an odds ratio (OR), which was calculated by using the formulae given in the Appendix (calculation of study-specific ORs).
To enable a comparison of the studies, I used the metaanalysis procedure of Yusuf et al. (73) . Details of the calculations are given in the appendix (calculation of summary ORs).
In brief, for each study (i), the expected number (Ei) of endotoxin-positive patients among those in whom GN bacteremia was detected was calculated, assuming statistical independence from the marginal totals in a two-by-two summed to produce a grand total (GT) and total variance (VT), respectively. From these totals, the summary ORs and their 95% confidence intervals (95% CIs) were calculated.
Data aggregation and sensitivity analysis. I began the analysis with all of the studies divided into two groups on the basis of which of the two versions of the assay, GLAL or CLAL, was used. A subgroup analysis was conducted by using only studies in which the proportion of patients with GN bacteremia was in the range of 13 to 40% (as in several large series [6, 22, 53, 71, 74] ), after it was found that many of the studies in which this proportion was outside of this range were designed for purposes other than to examine the use of LAL as a diagnostic test for unscreened patients with suspected sepsis.
The homogeneity of the concordance among the studies in each analysis was tested as described by Yusuf et al. (73) (see Appendix [calculation of summary ORs]). A finding of significant heterogeneity indicates that the variation in concordance among studies is more than could be expected from random variation. Summary estimates may be inappropriate in cases of significant heterogeneity.
Diagnostic utility. For each analysis, a calculation of sensitivity, specificity, and positive predictive value (PPV) was derived from the formulae as given in the Appendix (calculation of assay parameters).
RESULTS
Forty-five studies were identified; those studies reported the results for a total of 2,539 patients with suspected GN sepsis. There were only 43 separate publications because two publications (45, 52) each provided the results of two studies. A total of 29 studies used the GLAL assay (Table 1 ) and 16 studies used the CLAL assay ( Table 2 ). The concordance between the detection of endotoxemia and GN bacteremia in these studies is illustrated in Fig. 1 .
In 24 studies sepsis was suspected on the basis of fever and clinical assessment. In nine studies blood for culture and plasma were drawn from patients with suspected sepsis in the settings of specific illnesses such as malnutrition (37, 50) , pancreatitis (23) , and obstructive jaundice (4, 44) or following abdominal surgery (25, 26, 33) or liver transplantation (5) . Nine studies were limited to patients with specific infections such as typhoid fever (1, 9, 45, 48) , salmonellosis (45) , plaque (10, 11) , or meningococcemia (8, 29) . These patients were usually selected on the basis of a clinical diagnosis supplemented by confirmatory microbiological testing either by a positive culture for the specific pathogen from any site or by serology. One study (69) included only patients with microbiologically documented urological sepsis. The sensitivity limit for GLAL studies was usually in the range of 0.5 to 10 ng/ml, and that for CLAL studies was in the range of 10 to 500 pg/ml. This variability in sensitivity limits reflects the nonuniform potency among both the different reference endotoxin standards and the LAL reagents used in each study. In addition, the method of plasma pretreatment was more commonly by the dilution and heating method in the CLAL studies than in the GLAL studies (10 of 16 versus 7 of 29 studies).
Diagnostic utility. As an aggregate result, of the 2,539 patients from the 45 studies, GN bacteremia was detected in 615 (24%) of them. However, there was a large range in the pretest probability for GN bacteremia in individual studies (4 to 86%). Moreover, the derivation of a summary OR incorporates a formal test for heterogeneity which was highly significant in the two series of studies (Table 1 and 2).
Of 10 studies in which the prevalence of GN bacteremia was 50% or greater, microbiological documentation of GN sepsis by serology or cultural isolation of the organism from blood or another site was either an elective or an obligate requirement for patient inclusion in 7 studies (1, 8, 9, 11, 45, 48, 69) . Of eight studies in which the prevalence of GN bacteremia was 10% or less, five (4, 5, 25, 33, 44) were studies of endotoxemia occurring in the setting of obstructive jaundice or abdominal surgery.
Comparison of the summary results for studies that used the CLAL assay versus those that used the GLAL assay gave similar results for concordance (6.3, 4.4 to 9.1, and 8.4, 5.9 to 11.8, respectively [values are summary ORs, 95% CIs]), sensitivity (54 and 53%, respectively), and PPV (40 and 49%, respectively). Further comparison of studies that used the CLAL assay versus those that used the GLAL assay was limited to the 22 studies (9 used the CLAL assay and 13 used the GLAL assay) in which the percentage of patients having GN bacteremia in each study was in the range 13 to 40%. In the 9 studies that used the CLAL assay, the assay sensitivity was 62% (74 of 119 patients) and the PPV was 35% (74 of 214 patients). Overall, in the 13 studies that used the GLAL assay, the assay sensitivity was 51% (82 of 161 patients) and the PPV was 50% (82 of 163 patients). The summary ORs (with 95% CIs) indicate that the concordance with GN bacteremia was significantly less for the CLAL assay (3.6, 2.3 to 5.6) than for the GLAL assay (20.1, 12.5 to 32.4). Recalculation of the chi-square test for heterogeneity yielded results for the two series that were not statistically significant, a finding that is consistent with the absence of heterogeneity.
Bacteriology. The identifications of the isolates that caused bacteremia in 387 patients from 34 studies were tallied (Table  3) . Endotoxemia was detected in 79 (68%) of 116 patients with bacteremia caused by an organism that was not a member of the family Enterobacteriaceae (non-Enterobacteriaceae), whereas endotoxemia was detected in only 120 (45%) of 269 patients with bacteremia caused by a member of the family Enterobacteriaceae or an anaerobe (chi-square, 16.9; P < 0.001; degrees of freedom = 1; Table 3 ). This difference was also apparent for patients with GN bacteremias in whom a fatal outcome had been recorded; endotoxemia was found in 26 of VOL. 32, 1994 on August 27, 2017 by guest http://jcm.asm.org/ Downloaded from With any diagnostic test, caution is required in its interpretation in patient populations in whom the pretest probability of the disease of interest is unusually high or low. A positive test for the occurrence of endotoxin in patients with a low frequency of GN bacteremia may represent "intestinal endotoxemia," as in the studies of patients with obstructive jaundice or undergoing surgical procedures (4, 5, 33, 44) , or a false-positive result because of ex vivo contamination, which may occur at rates as high as 9% even with experienced personnel (71) . The clinical significance of intestinal endotoxemia, which may reach levels that are seen in patients with acute, potentially lethal infections, is unclear because these increases are associated with hemodynamic changes that are often clinically trivial and not predictive of any subsequent morbidity (3, 12, 56) . On the other hand, many studies with a rate of GN bacteremia greater than 50% examined patient populations that had been screened to include patients with specific types of sepsis.
The presumption that, in patients with GN sepsis, GN bacteremia and endotoxemia must always be associated with each other, even at low levels, in part contributed to earlier criticisms of the LAL assay (21, 65) and stimulated the development of a more sensitive version. If this presumption is correct, then a more sensitive assay should substantially increase the sensitivity for the detection of GN bacteremia in patients with sepsis. However, this was not found to be the case because the sensitivity in the 16 studies that used the CLAL assay (54%) was only 1% higher than that in the 29 studies that used the GLAL assay (53%).
Even after excluding the studies that had patients with an unusually high or low prevalence of GN bacteremia, the CLAL assay showed an increase in sensitivity of only 11% (62 versus 51%) but a substantial decrease in specificity and PPV in comparison with those of the GLAL assay. Recalculation of the test for heterogeneity yielded a result consistent with its absence, although this should not be taken as evidence that the studies were truly homogeneous (27) . Indeed, there were both a higher proportion of bacteremias caused by non-Enterobacteriaceae reported in studies that used the CLAL assay (65 of 112) than was the case for studies that used the GLAL assay (51 of 273) and also a more common use of the dilution and heating method of plasma pretreatment, a method considered to be more efficient than the chloroform technique (28, 32a). These differences could presumably account for some of the increase in sensitivity in the studies that used the CLAL assay.
What are the practical implications? In a hypothetical population of 100 patients with suspected sepsis for whom cultures of blood would be required, of which 20 have GN bacteremia, the GLAL assay would be positive for 10 of these GN bacteremic patients and produce discordant positive results for 10 patients without GN bacteremia. The CLAL assay, on the other hand, would be positive for 12 of the GN bacteremic patients but would generate discordant positive results for 24 patients.
An important determinant of the utility of the assay, which this analysis revealed, is the type of GN bacteremia being sought. For example, endotoxemia is found in association with only 32% of bacteremias caused by Enterobacter species but is found in association with 73% of meningococcemias. A study by Porter et al. (54) , which was excluded from the present analysis because a rabbit bioassay for endotoxin was used to detect endotoxin in serum, also failed to detect endotoxemia in five patients with bacteremia caused by an Enterobacteriaceae; for three of these patients the outcome was fatal. Opal (51) found that endotoxin levels in patients with bacteremia caused by Pseudomonas species, meningococci, and the nonfermenta-X X X X X X tive GN organisms tended to be higher than in patients with bacteremias caused by Escherichia coli, Klebsiella species, and Enterobacter species.
Because the intravascular compartment is seldomly the primary site of infection, mechanisms which enable GN bacteria and endotoxin to persist at detectable levels in this compartment, such as serum resistance and plasma lipoprotein binding (7, 43) , respectively, warrant closer scrutiny in the interpretation of the LAL assay.
Nearly all GN bacteria isolated from the blood of patients are resistant to killing by normal serum, whereas one-third or fewer of the GN bacteria isolated from mucosal surfaces are susceptible (55) , although the mechanisms of serum resistance vary (35, 38, 61) . It is plausible that the ability of particular invasive bacteria to shed endotoxin from their surfaces, as is found with the systemic N. meningitidis isolates (2, 49) , is a property associated with resistance to serum. As a consequence, it would be expected that bacteremias with these organisms will be associated with the copresence of shed endotoxin in quantities large enough to be easily detected in plasma, even by electron microscopy (7) . By contrast, with Enterobacteriaceae such as the K-1 strain of E. coli, the resistance to serum is dependent on the coating of the cell with a minimum amount of capsular polysaccharide without a change in lipopolysaccharide expression (42) . It 
